Literature DB >> 1921313

Segregation of genes from donor strain during the production of recombinant congenic strains.

L F van Zutphen1, M Den Bieman, A Lankhorst, P Demant.   

Abstract

Recombinant congenic strains (RCS) constitute a set of inbred strains which are designed to dissect the genetic control of multigenic traits, such as tumour susceptibility or disease resistance. Each RCS contains a small fraction of the genome of a common donor strain, while the majority of genes stem from a common background strain. We tested at two stages of the inbreeding process in 20 RCS, derived from BALB/cHeA and STS/A, to see whether alleles from the STS/A donor strain are distributed over the RCS in a ratio as would theoretically be expected. Four marker genes (Pep-3; Pgm-1; Gpi-1 and Es-3) located at 4 different chromosomes were selected and the allelic distribution was tested after 3-4 and after 12 generations of inbreeding. The data obtained do not significantly deviate from the expected pattern, thus supporting the validity of the concept of RCS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921313     DOI: 10.1258/002367791780808329

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  3 in total

1.  Quantitative trait locus analysis using recombinant inbred intercrosses: theoretical and empirical considerations.

Authors:  Fei Zou; Jonathan A L Gelfond; David C Airey; Lu Lu; Kenneth F Manly; Robert W Williams; David W Threadgill
Journal:  Genetics       Date:  2005-05-06       Impact factor: 4.562

2.  The recombinant congenic strains--a novel genetic tool applied to the study of colon tumor development in the mouse.

Authors:  C J Moen; M A van der Valk; M Snoek; B F van Zutphen; O von Deimling; A A Hart; P Demant
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

3.  Evidence for a multigenic system controlling methyl-beta-carboline-3-carboxylate (beta-CCM)-induced seizures.

Authors:  B Martin; C Marchaland; G Chapouthier; R Motta
Journal:  Behav Genet       Date:  1994-05       Impact factor: 2.805

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.